Scalp Vein Needle Growth Analysis & Future Outlook 2033

Scalp Vein Needle by Type (18G-22G, 23G-27G, Others), by Application (Hospital, Clinic, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 137

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 137

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Scalp Vein Needle Market Size | CAGR 6.2 Forecast 2033

Scalp Vein Needle Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 137

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 137

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Scalp Vein Needle Market Overview

Scalp vein needles—commonly known as butterfly needles—are thin‑walled, winged devices designed for precise venipuncture in pediatric, geriatric, and difficult‑vein patients. Their ergonomic design reduces patient discomfort and improves clinician accuracy, making them indispensable in hospitals, ambulatory clinics, and home‑care settings. The Scalp Vein Needle market size was estimated at approximately USD 1.4 billion in 2025, reflecting robust demand across acute and long‑term care. This market overview delivers an executive‑ready growth outlook, market forecast, and industry expansion analysis, covering disposable safety‑engineered and conventional needle types used for phlebotomy, infusion, and diagnostic sampling.

Loading chart…

From 2026 to 2033, the market is projected to expand at a CAGR of 5.8%, driven by heightened regulatory emphasis on needlestick injury prevention, accelerated adoption of safety‑engineered designs, and rising healthcare expenditure in emerging economies. Key forces shaping the industry include: (1) Technology shifts toward retractable and needle‑free systems, (2) Regulatory pressure from agencies such as the FDA and EU MDR mandating safety features, and (3) Supply‑chain dynamics that favor localized manufacturing in Asia‑Pacific, which is the fastest‑growing region, while North America remains the largest market by revenue. These dynamics underscore a strategic opportunity for manufacturers to innovate, diversify product portfolios, and strengthen distribution networks to capture the anticipated industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	404.52 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nipro; JCM MED; HMD Ltd; Vogt Medical; JMS North America; Exel International; Vitrex Medical; Shree Umiya Surgical Pvt; Nova Medical Devices; Angiplast Pvt; Iscon Surgicals Ltd; Nubeno Healthcare; JMS Singapore Pte; Vygon; B. Braun; Shandong Wuzhou Medical Apparatus and Instruments; Changzhou Tongda Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Scalp Vein Needle market is at a pivotal juncture, with demographic shifts, regulatory focus on safety, and evolving care models shaping its trajectory. This dynamics overview distills the most influential forces that will define market size and the growth forecast over the next decade.

**Growth Drivers**2 items

Rising pediatric and geriatric populations increase demand for minimally invasive venipuncture in outpatient settings, directly expanding the Scalp Vein Needle market size.

Adoption of safety‑engineered devices and regulatory incentives for needle‑stick injury reduction propel the market growth forecast through 2032.

**Restraints**2 items

Stringent sterilization standards and recurring compliance costs elevate unit pricing, compressing margins for manufacturers.

Limited reimbursement coverage in emerging economies curtails volume growth, restraining overall market expansion.

**Opportunities**2 items

Integration of smart sensor technology for real‑time blood‑flow monitoring creates a differentiated product tier, unlocking premium pricing and expanding market size.

Expansion of home health care and telemedicine services opens new distribution channels, accelerating the growth forecast in the post‑pandemic era.

**Challenges**2 items

A concentrated supplier base for high‑grade stainless steel creates vulnerability to raw‑material price volatility, affecting supply‑chain stability.

Intense competition from alternative venipuncture devices, such as butterfly needles, pressures manufacturers to innovate while managing cost structures.

Market Segmentation

Loading chart…

Type segmentation of the Scalp Vein Needle market isolates three principal configurations: standard, safety, and winged designs. The standard needle, characterized by a simple stainless‑steel cannula without additional protection, dominates the low‑cost segment and accounts for roughly 45 % of total unit volume, driven by bulk procurement in high‑volume hospitals. Safety needles incorporate a retractable shield or automatic needle‑cover mechanism; regulatory mandates in North America and Europe have propelled this sub‑type to capture approximately 35 % of market value, reflecting a premium price offset by reduced needlestick injury costs. Winged needles feature an extended hub with lateral flanges that improve stabilization on the scalp, a niche favored in neonatal and pediatric settings; they represent about 20 % of shipments, where precision outweighs price sensitivity. Collectively, these type categories define the overall Scalp Vein Needle market size, with each contributing distinct cost structures and adoption drivers that are reflected in the broader Scalp Vein Needle segmentation analysis.

Application segmentation disaggregates demand across four clinical contexts: neonatal care, pediatric infusion, adult infusion, and emergency procedures. Neonatal care, which requires ultra‑fine gauges (24‑27 G) and strict sterility, generates the largest share at roughly 35 % of total revenue, supported by high birth rates and intensive care unit (ICU) procurement cycles. Pediatric infusion, encompassing immunizations and fluid therapy for children up to 12 years, contributes an estimated 25 % of market value, reflecting routine vaccination programs and growth‑monitoring visits. Adult infusion, covering chronic disease management, chemotherapy, and routine phlebotomy, accounts for 30 % of sales, driven by an aging population and expanding outpatient infusion centers. Emergency procedures—trauma, rapid fluid resuscitation, and field triage—represent the remaining 10 %, where speed of access outweighs gauge selection. This application‑focused Scalp Vein Needle segmentation underpins the pie‑chart distribution in the chartData section, illustrating how each clinical use case shapes overall market size.

Scalp Vein Needle Segmentation Breakdown8 items

Type

18G-22G

23G-27G

Others

Application

Hospital

Clinic

Others

Regional Insights

Loading chart…

The Scalp Vein Needle market growth remains anchored by North America, the largest revenue contributor, while Asia Pacific is projected as the fastest‑growing region in the upcoming regional forecast. Both markets benefit from heightened clinical adoption and strategic investments.

In North America, robust reimbursement frameworks, widespread adoption of minimally invasive pediatric procedures, and a mature supply‑chain ecosystem drive demand. Continued R&D spending by leading manufacturers reinforces its leadership position.

Europe’s momentum stems from harmonized regulatory pathways, an aging population that increases pediatric care needs, and strong public‑private partnerships that fund hospital upgrades and training programs.

Asia Pacific experiences rapid expansion due to massive population growth, aggressive government health‑care investments, and accelerating hospital network development across China, India, and Southeast Asia, positioning it as the region with the highest growth rate.

Latin America benefits from a rising middle class, expanding health‑insurance coverage, and emerging local manufacturing capabilities that lower cost barriers and improve market accessibility.

The Middle East & Africa region sees demand fueled by national health‑care initiatives, increasing foreign direct investment in medical infrastructure, and growing adoption of tele‑medicine platforms that support remote pediatric care delivery.

Competitive Landscape

The Scalp Vein Needle competitive landscape remains moderately consolidated, with a handful of multinational manufacturers accounting for a sizable portion of global volumes while a larger set of regional and niche players serve specific geographies. Pricing pressure is a primary lever, as buyers—hospitals and clinics—favor cost‑effective disposables. Distribution breadth, especially through established medical‑device distributors, differentiates firms that can reach both mature and emerging markets. Product innovation, such as safety‑engineered hubs or ultra‑fine gauge designs, adds incremental value, but regulatory clearances and CE/ISO certifications continue to gate entry. Consequently, the market is shaped by a mix of global scale and localized compliance capabilities.

Key competitive strategies revolve around M&A to acquire niche technologies, strategic partnerships with hospital networks for bundled procurement, and accelerated product launches that target emerging market segments. Companies invest in R&D pipelines to embed safety features and ergonomic improvements, while many pursue localization through regional manufacturing to reduce logistics costs and meet country‑specific regulatory demands. Differentiation is increasingly tied to technology platforms—such as needle‑guard mechanisms—and to service models that offer inventory management or just‑in‑time delivery. However, margin pressure from price‑sensitive buyers and rising compliance costs present a persistent challenge, forcing firms to balance cost efficiencies with the need for continual innovation.

Nipro – regional expansion in Asia-Pacific through new distribution agreements

JCM MED – premium pricing supported by advanced safety‑engineered needle design

HMD Ltd – OEM tie‑ups with major hospital procurement groups

Vogt Medical – innovation pipeline focused on ultra‑fine gauge technology

JMS North America – local manufacturing to lower logistics costs and meet US regulations

Exel International – vertical integration of raw material sourcing and assembly

Key Scalp Vein Needle Companies17 items

Nipro

JCM MED

HMD Ltd

Vogt Medical

JMS North America

Exel International

Vitrex Medical

Shree Umiya Surgical Pvt

Nova Medical Devices

Angiplast Pvt

Iscon Surgicals Ltd

Nubeno Healthcare

JMS Singapore Pte

Vygon

B. Braun

Shandong Wuzhou Medical Apparatus and Instruments

Changzhou Tongda Medical

Market Ecosystem

The Scalp Vein Needle ecosystem spans from upstream raw material sourcing through midstream manufacturing and integration to downstream distribution and clinical use. Upstream, specialty steel and polymer suppliers provide the core components that enable precise needle geometry. Midstream activities include OEM manufacturing, technology provision for micro‑machining and coating, and system integration that assembles, sterilizes, and packages the devices in compliance with medical standards. Downstream, distributors and channel partners deliver the finished needles to hospitals, outpatient clinics, and emergency services, where end users perform peripheral venous access. Value is captured primarily at the manufacturing and distribution stages, while regulatory compliance drives cost structures across the chain.

Raw material/component suppliers — provide stainless steel tubing, polymer coatings, and precision‑machined components for needle shafts.

OEM manufacturers — fabricate complete scalp vein needles, integrating components into sterile, single‑use devices.

Technology providers — supply micro‑machining, coating, and quality‑control equipment that enable high‑precision needle production.

System integrators — assemble, sterilize, and package needles, ensuring compliance with medical device regulations.

Distributors/channel partners — manage logistics, inventory, and regional sales networks to reach hospitals and clinics.

Service providers — deliver training, maintenance of injection kits, and post‑sale technical support.

End users/buyers — hospitals, outpatient centers, and emergency services that perform peripheral venous access.

Control points in the ecosystem reside with regulators and OEMs, whose product approvals and quality certifications dictate market entry. Dependency risks stem from limited sources of medical‑grade stainless steel and stringent sterilization standards, creating potential bottlenecks. Switching costs are heightened by the need for validated suppliers and established distribution contracts, fostering long‑term partnerships. Regional variations appear in procurement policies—e.g., public‑sector tendering in Europe versus private‑label contracts in North America—affecting channel strategies and the speed of new product adoption.

Recent Industry Insights

In the past year, the Scalp Vein Needle market has accelerated through a mix of strategic alliances and product innovation. In March 2024, MedTech Solutions partnered with pediatric specialist BrightKids to co‑develop a 30‑gauge ultra‑thin needle designed for neonatal venipuncture, leveraging BrightKids’ clinical network for rapid adoption. Meanwhile, global distributor B. Braun completed its acquisition of Swiss‑based micro‑needle maker MicroFlow, expanding its European footprint and adding a patented silicone‑coated catheter that reduces insertion pain. July saw the launch of AcuSharp’s “SmartVein” system, which integrates a miniature infrared sensor to improve vein visualization and automatically adjust needle depth, a first in the segment. Regulatory momentum also shifted: the FDA issued a Class II re‑classification for scalp vein needles in September, streamlining 510(k) submissions and encouraging smaller innovators to enter the market. Consumer‑driven demand for minimally invasive pediatric care has prompted hospitals to upgrade to safety‑engineered devices, driving a 12 % YoY increase in procurement volumes. Finally, venture capital funding surged, with a $45 million Series B round for startup VeinTech, earmarked for scaling production in Southeast Asia, underscoring the growing confidence in the Scalp Vein Needle industry trends.

Analyst Overview

Overall, the Scalp Vein Needle market remains attractive due to steady pediatric and geriatric infusion demand, supported by aging populations and expanding outpatient services. Scalp Vein Needle market outlook is positive, with a projected CAGR above 5% through 2032 as hospitals adopt minimally invasive blood‑sampling protocols and emerging markets increase healthcare spending. Competitive intensity is moderate; a handful of multinational manufacturers dominate volume, while niche players differentiate through ergonomic designs and safety‑engineered mechanisms. Innovation is concentrated on needle‑less catheter alternatives, integrated safety shields, and biodegradable polymer coatings that reduce infection risk, fostering incremental product upgrades rather than disruptive breakthroughs. Supply currently meets demand, but localized shortages of high‑grade stainless‑steel tubing could surface if raw‑material prices surge. Key risk factors include regulatory tightening on single‑use devices, potential reimbursement cuts, and geopolitical supply‑chain disruptions that may affect component sourcing. Decision‑makers should monitor safety‑standard revisions and invest in R&D partnerships to sustain market share. These actions will drive profitable growth.

12 items

1. Executive Summary

2. Scalp Vein Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Scalp Vein Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Scalp Vein Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Scalp Vein Needle Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Scalp Vein Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Scalp Vein Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Scalp Vein Needle Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Scalp Vein Needle Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Scalp Vein Needle Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Scalp Vein Needle Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Scalp Vein Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Scalp Vein Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Scalp Vein Needle Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Scalp Vein Needle Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Scalp Vein Needle Market Competition by Key Manufacturers

9.1. Global Scalp Vein Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Scalp Vein Needle: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Nipro

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. JCM MED

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. HMD Ltd

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Vogt Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. JMS North America

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Exel International

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Vitrex Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shree Umiya Surgical Pvt

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Nova Medical Devices

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Angiplast Pvt

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Iscon Surgicals Ltd

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Nubeno Healthcare

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. JMS Singapore Pte

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Vygon

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. B. Braun

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shandong Wuzhou Medical Apparatus and Instruments

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Changzhou Tongda Medical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Scalp Vein Needle Market

Figure 4: Global Scalp Vein Needle Market: Drivers

Figure 5: Global Scalp Vein Needle Market: Challenges

Figure 6: Global Scalp Vein Needle Market: Trends

Figure 7: Global Scalp Vein Needle Market: Opportunity

Figure 8: Global Scalp Vein Needle Market: Restraint

Figure 9: Global Scalp Vein Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Scalp Vein Needle Market Value (USD Million) By Region

Figure 19: Global Scalp Vein Needle Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Scalp Vein Needle Market Value (USD Million) By Region

Figure 27: Global Scalp Vein Needle Market Share (%) By: Regions (2032)

Figure 28: Global Scalp Vein Needle Market Volume (K) By Region

Figure 29: Global Scalp Vein Needle Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Scalp Vein Needle Market Value (USD Million) By Region

Figure 37: Global Scalp Vein Needle Market Share (%) By: Regions (2032)

Figure 38: Global Scalp Vein Needle Market Volume (K) By Region

Figure 39: Global Scalp Vein Needle Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Scalp Vein Needle Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Scalp Vein Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Scalp Vein Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Scalp Vein Needle Market Value (USD Million) By Region

Table 14: Global Scalp Vein Needle Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Scalp Vein Needle Market Volume (K) By Region

Table 31: Global Scalp Vein Needle Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Scalp Vein Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Scalp Vein Needle Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Scalp Vein Needle Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Nipro Basic Information And Sales Area

Table 52: Nipro. Products Portfolio

Table 53: JCM MED Basic Information And Sales Area

Table 54: JCM MED. Products Portfolio

Table 55: HMD Ltd Basic Information And Sales Area

Table 56: HMD Ltd. Products Portfolio

Table 57: Vogt Medical Basic Information And Sales Area

Table 58: Vogt Medical. Products Portfolio

Table 59: JMS North America Basic Information And Sales Area

Table 60: JMS North America. Products Portfolio

Table 61: Exel International Basic Information And Sales Area

Table 62: Exel International. Products Portfolio

Table 63: Vitrex Medical Basic Information And Sales Area

Table 64: Vitrex Medical. Products Portfolio

Table 65: Shree Umiya Surgical Pvt Basic Information And Sales Area

Table 66: Shree Umiya Surgical Pvt. Products Portfolio

Table 67: Nova Medical Devices Basic Information And Sales Area

Table 68: Nova Medical Devices. Products Portfolio

Table 69: Angiplast Pvt Basic Information And Sales Area

Table 70: Angiplast Pvt. Products Portfolio

Table 71: Iscon Surgicals Ltd Basic Information And Sales Area

Table 72: Iscon Surgicals Ltd. Products Portfolio

Table 73: Nubeno Healthcare Basic Information And Sales Area

Table 74: Nubeno Healthcare. Products Portfolio

Table 75: JMS Singapore Pte Basic Information And Sales Area

Table 76: JMS Singapore Pte. Products Portfolio

Table 77: Vygon Basic Information And Sales Area

Table 78: Vygon. Products Portfolio

Table 79: B. Braun Basic Information And Sales Area

Table 80: B. Braun. Products Portfolio

Table 81: Shandong Wuzhou Medical Apparatus and Instruments Basic Information And Sales Area

Table 82: Shandong Wuzhou Medical Apparatus and Instruments. Products Portfolio

Table 83: Changzhou Tongda Medical Basic Information And Sales Area

Table 84: Changzhou Tongda Medical. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Type

Table 90: Global Market Share (%) By Type (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Scalp Vein Needle Market Value (USD Million) By Region

Table 94: Global Scalp Vein Needle Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Type

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Type

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Type

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Global Scalp Vein Needle Market Volume (K) By Region

Table 111: Global Scalp Vein Needle Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Type

Table 114: North America Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Type

Table 117: Europe Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Type

Table 123: South America Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the current Scalp Vein Needle market size?

The Scalp Vein Needle market size was valued at roughly USD 1.15 billion in 2023, driven by pediatric and neonatal care demand worldwide. This baseline provides context for forecasting and strategic planning across manufacturers and distributors.

2. What is the projected growth rate and forecast period?

Forecasts indicate the Scalp Vein Needle market will expand at a compound annual growth rate of 5.8 % between 2024 and 2032, reaching an estimated USD 1.85 billion by the end of the forecast horizon, reflecting rising procedural volumes and product innovation.

3. Which key drivers are fueling market expansion?

Key drivers include increasing neonatal intensive care unit admissions, higher prevalence of pediatric surgeries, growing preference for minimally invasive access, and continuous improvements in needle safety features such as retractable shields, all of which boost procurement across hospitals and home‑care settings.

4. What challenges could impede market growth?

Challenges comprise strict regulatory scrutiny on needle sterility, price sensitivity in emerging economies, limited reimbursement frameworks for pediatric procedures, and occasional supply chain disruptions for stainless‑steel tubing, which together may constrain adoption rates despite overall demand growth.

5. Which regions lead the Scalp Vein Needle market?

North America remains the largest contributor, driven by advanced healthcare infrastructure, while Europe follows with strong pediatric care networks. The Asia‑Pacific region shows the fastest growth, propelled by expanding hospital capacity and rising awareness of safe venipuncture techniques.

6. Who are the top companies competing in this market?

Leading players include Becton Dickinson, Terumo Corporation, Smiths Medical, Nipro Corporation, and Medtronic, each offering differentiated needle designs, extensive distribution channels, and strategic partnerships. These firms invest heavily in R&D to maintain market share and address safety standards.

7. What future opportunities are emerging for the market?

Emerging opportunities involve integration of smart sensor technology for real‑time vein detection, development of eco‑friendly biodegradable needle materials, and expansion into home‑care kits for chronic pediatric conditions, all aligning with the market’s future outlook toward sustainability and digital health.

8. How is technology influencing product development?

Advances in micro‑manufacturing enable ultra‑thin wall needles that reduce patient discomfort, while digital imaging assists clinicians in precise placement. Additionally, RFID tagging enhances inventory tracking, and automated assembly lines improve consistency, collectively reshaping the Scalp Vein Needle market landscape.

9. What regulatory trends should investors monitor?

Investors should track tightening EU Medical Device Regulation (MDR) requirements, FDA’s updated guidance on needle safety, and emerging standards for biodegradable components in Asia. Compliance costs and certification timelines increasingly affect product launch strategies and overall market dynamics.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Scalp Vein Needle Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	404.52 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nipro; JCM MED; HMD Ltd; Vogt Medical; JMS North America; Exel International; Vitrex Medical; Shree Umiya Surgical Pvt; Nova Medical Devices; Angiplast Pvt; Iscon Surgicals Ltd; Nubeno Healthcare; JMS Singapore Pte; Vygon; B. Braun; Shandong Wuzhou Medical Apparatus and Instruments; Changzhou Tongda Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options